✦ LIBER ✦

Inhibitors of the complement system currently in development for cardiovascular disease

✍ Scribed by M. K. Pugsley; M. Abramova; T. Cole; X. Yang; W. S. Ammons

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Drug design using the example of the com

✍ Svetlana Bureeva; Julian Andia-Pravdivy; Alexander Kaplun 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 248 KB

Incidence of risk factors for developing

✍ Amir, Omalhassan ;Hassan, Yahaya ;Sarriff, Azmi ;Awaisu, Ahmed ;Abd. Aziz, Noori 📂 Article 📅 2009 🏛 Springer 🌐 Dutch ⚖ 183 KB

Hunting for biomarkers: The complement s

✍ Svetlana Hakobyan; Mohammed Aiyaz; Alexandra Stretton; Martina Sattlecker; Richa 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 69 KB

The role of the renin-angiotensin system

✍ Thomas Unger 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 408 KB

Development of Aptamer oligonucleotides

✍ Li, Weibin; Wang, Kaiyu; Zhao, Meng; Yang, Xiangyue; Chen, Min; Lan, Xiaopeng 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 239 KB

Dysregulation of the complement system i

✍ T.M. Woodruff; J.D. Lee; S.M. Taylor; P.G. Noakes 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 65 KB